·Clinical Research· Current Issue  IF in JCR  CiteScore  ·Submission·  In Press  Recent Accepted  PMC  RSS 


Citation
: Ren MW, Du Y, Ren S, Tang CY, He JF. Epstein-Barr virus-encoded small RNAs in idiopathic orbital inflammatory pseudotumor tissues: a comparative case series. Int J Ophthalmol  2017;10(8): 1268-1272

 

Epstein-Barr virus-encoded small RNAs in idiopathic orbital inflammatory pseudotumor tissues: a comparative case series

 

Min-Wei Ren1,2, Yi Du1, Shan Ren2, Cheng-Ye Tang1, Jian-Feng He1

 

1Department of Ophthalmology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China

2Department of Ophthalmology, Liuzhou People's Hospital, Liuzhou 545006, Guangxi Zhuang Autonomous Region, China

Co-first authors: Min-Wei Ren and Yi Du

Correspondence to: Jian-Feng He. Department of Ophthalmology, the First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. hejianf@foxmail.com

Received: 2016-09-17        Accepted: 2017-05-24

 

Abstract

AIM: To investigate the positive rate and types of cells that express Epstein-Barr virus-encoded small RNAs (EBERs) and to determine the distribution of EBER-expressing cells in idiopathic orbital inflammatory pseudotumor (IOIP) tissues.

METHODS: We retrospectively examined 40 archived paraffin specimens from two teaching hospitals in Southern China between January 2007 and January 2015 that were pathologically determined to exhibit IOIP. Eleven concurrent paraffin specimens of thyroid-associated ophthalmopathy (TAO) composed the control group. In situ hybridization was performed to detect EBERs. Immunohistochemistry was employed to detect CD3, CD20, Vimentin, and smooth muscle actin (SMA), and the positive rate, types of positive cells, and distribution and location of EBERs were evaluated.

RESULTS: The positive expression rate of EBERs was 47.5% (19/40) in the IOIP group, which was significantly higher than that in the TAO group [0 (0/11), P=0.011]. In the IOIP group, the lymphocyte infiltrative subtype, fibrotic subtype, and mixed subtype exhibited EBER-positive rates of 57.1% (12/21), 12.5% (1/8), and 54.5% (6/11), respectively, and no significant differences were found between these subtypes (P=0.085). Positive signals of EBERs were mainly present in medium-small lymphocytes between or around follicles and in the nuclei of activated immunoblasts (14/19).

CONCLUSION: The positive rate, types, and distribution of EBER-expressing cells in IOIP have been documented. These findings are conducive for a better understanding of the underlying mechanisms of Epstein-Barr virus infection in IOIP pathogenesis.

KEYWORDS: Epstein-Barr virus; Epstein-Barr virus-encoded small RNAs; thyroid eye disease; Graves’ ophthalmopathy; idiopathic orbital inflammatory disease

DOI:10.18240/ijo.2017.08.14

 

Citation: Ren MW, Du Y, Ren S, Tang CY, He JF. Epstein-Barr virus-encoded small RNAs in idiopathic orbital inflammatory pseudotumor tissues: a comparative case series. Int J Ophthalmol  2017;10(8): 1268-1272

 

INTRODUCTION

Idiopathic orbital inflammatory pseudotumor (IOIP), also known as orbital pseudotumor, was first described by Birech-Hirsechfeld in 1905 as an intra-orbital inflammatory process that was non-specific and non-neoplastic[1-6]. Currently, the underlying pathological mechanisms of IOIP have yet to be fully understood[7-8]. Pender proposed that infection by Epstein-Barr virus (EBV) might be a trigger for multiple chronic autoimmune diseases[9-10]. Jin et al[11] found that the positive rate of EBV DNA in the plasma samples of IOIP patients was three times as much as control group. Nevertheless, the types of cells and their distribution and specific locations in IOIP tissues are not fully understood.

Epstein-Barr virus-encoded small RNAs (EBERs) are the most abundant viral transcripts in cells with latent EBV infection[12]. EBER detection using in situ hybridization is considered the gold standard for determining and locating latent EBV infection[12]. It has been demonstrated that persistent transcription of EBERs occurs in almost every EBV-associated lesion[13]. The goal of this study is to examine the EBER-positive rate, types of EBER-positive cells, and the distribution of EBER-positive cells in IOIP tissues.

SUBJECTS AND METHODS

Ethics Statement  This retrospective study was approved by the institutional review board of the First Affiliated Hospital of Guangxi Medical University and followed the tenets of the Declaration of Helsinki. Written informed consent was provided by all study participants or their legal guardians.

Clinical Samples  The archived paraffin specimens of 40 continuous IOIP cases, which were pathologically determined between January 2007 and January 2015 at the First Affiliated Hospital of Guangxi Medical University and Liuzhou People's Hospital, were used as the case group. In addition, the paraffin specimens of 11 patients with thyroid-associated ophthalmopathy (TAO) who underwent orbital decompression or strabismus surgery during the same period composed the control group. Pathological classification of IOIP was based on the method of Henderson[14], and inflammatory pseudotumor tissues were classified into three subtypes: lymphocyte infiltrative subtype, fibrotic subtype, and mixed subtype. The diagnostic criteria of TAO were based on those of Bartley and Gorman[15]. All specimens were fixed with 10% neutral formalin and then sliced into 4-μm paraffin-embedded sections. All tissue sections were subjected to hematoxylin-eosin and immunohistochemical staining for pathological confirmation. In addition, each paraffin-embedded specimen was used to generate five continuous sections, which were used for in situ hybridization of EBERs as well as for immunohistochemical staining of CD3, CD20, Vimentin, and SMA.

In situ Hybridization of Epstein-Barr virus-encoded small RNAs  REMBRANDT® in situ Hybridisation and Detection Kits (PanPath, Netherlands) were used to detect EBERs, and digoxin-labeled oligonucleotide probes were used to detect EBER1 and EBER2 according to the manufacturer’s instructions.

Immunohistochemical Staining of CD3, CD20, Vimentin and SMA  Monoclonal antibodies against CD3, CD20, SMA, and Vimentin and the GTVisionTM Secondary Antibody Kit (GeneTech, Shanghai, China) were used for immunohistochemical staining according to the manufacturers’ instructions.

Statistical Analysis  SPSS 13.0 software was used for statistical analyses. Chi-square tests were used to compare the count data between groups. Independent samples t-test were used to compare the age between groups. A value of P<0.05 was considered statistically significant.

RESULTS

Epstein-Barr Virus-encoded Small RNA Expression in Idiopathic Orbital Inflammatory Pseudotumor and Thyroid-associated Ophthalmopathy  The positive EBER expression of IOIP group was significantly higher than that of TAO group (47.5% vs 0, P=0.011) (Table 1). In IOIP group, the lymphocyte infiltrative subtype, fibrotic subtype, and mixed subtype had EBER-positive rates of 57.1% (12/21), 12.5% (1/8) and 54.5% (6/11), respectively, which were not significantly different (P=0.085).

Table 1 The clinical features and EBERs expression in IOIP and TAO groups   n (%)

Characteristics

IOIP group

(n=40)

TAO group

(n=11)

P

Gender

 

 

0.0181

 Male

18 (45)

10 (90.9)

 

 Female

22 (55)

1 (9.1)

 

Age (a)

49.1±20.2

39.3±13.8

0.1362

Unilateral or bilateral involvement

 

<0.0011

 Unilateral

35 (87.5)

1 (9.1)

 

 Bilateral

5 (12.5)

10 (90.9)

 

EBERs expression

0.0111

+

19 (47.5)

0

 

-

21 (52.5)

11 (100)

 

EBER: Epstein-Barr virus-encoded small RNA; IOIP: Idiopathic orbital inflammatory pseudotumor; TAO: Thyroid-associated ophthalmopathy.1Pearson’s Chi-squared test with Yates’ continuity correction; 2Independent samples t-test.

 

Epstein-Barr Virus-encoded Small RNA-positive Cells in Idiopathic Orbital Inflammatory Pseudotumor  In situ hybridization revealed that the EBER-positive cells in IOIP tissues could be divided into two subtypes. The first category was lymphocytes, which included small-medium-sized lymphocytes and activated immunoblasts. Observation of the continuous sections after Immunohistochemical staining revealed that some of these cells were CD20+ B lymphocytes, although most of them could not be confirmed to express CD3 or CD20. The EBER-positive cells were mainly distributed in medium-small lymphocytes around follicles and in the nuclei of activated immunoblasts. In addition, three samples revealed that several ectopic folliculargerminal centers harbored 2-8 EBER-positive centroblasts. The second category included the spindle cells that proliferated in interstitial lesions and differentiated into fibroblasts/myofibroblasts. In total, three specimens with EBER-positive lymphocytes as well as EBER expression in the nuclei of mesenchymal spindle cells were observed (Figure 1). The density and distribution of EBER-positive cells in the 19 specimens are listed in Table 2. In contrast, in situ hybridization revealed that the inflammatory cells and spindle cells that infiltrated into extraocular muscle and caused hyperplasia were both EBER negative (Figure 2).

Min-Wei Ren1

Figure 1 In situ hybridization revealed positive EBER expression in the following cells or locations  A: Medium-small lymphocytes in IOIP tissues (×400); B: Medium-small lymphocytes in IOIP tissues as well as the nuclei of immunoblasts (×400); C: The nuclei of CD20+ B immunoblasts (×200); D: The nuclei of activated immunoblasts (×400); E: Centroblasts in the germinal centers of ectopic lymphoid follicles as well as lymphocytes around the follicles (in nuclei) (×200); F: Nuclei of mesenchymal spindle cells and lymphocytes (×400).

Min-Wei Ren2

Figure 2 In situ hybridization revealed negative EBER expression in orbital tissues of the extraocular muscles of TAO patients  A: Inflammatory cells and spindle cells (×200); B: Adipose hyperplasia (×200).

 

Table 2 The density and distribution of EBER-positive cells in IOIP specimens

Case No.

Gender

Age (a)

Laterality

Pathological type

EBERs+ cells/section

Type and distribution of EBER+ cells

1

Female

41

Right

Lymphocyte dominant

25

Inter-follicular small lymphocytes and immunoblasts

2

Male

39

Right

Lymphocyte dominant

80-100

Inter-follicular medium-small lymphocytes and immunoblasts

3

Male

32

Right

Lymphocyte dominant

5

Inter-follicular immunoblasts

4

Female

53

Right

Mixed

2

Inter-follicular immunoblasts

5

Male

35

Right

Lymphocyte dominant

>200

Inter-follicular small lymphocytes, medium-sized lymphocytes, and large immunoblasts, mesenchymal spindle cells, 8 positive centroblasts in 1 germinal center.

6

Female

39

Bilateral

Lymphocyte dominant

4

Inter-follicular small lymphocytes and immunoblasts

7

Female

70

Right

Lymphocyte dominant

7

Inter-follicular small lymphocytes and immunoblasts

8

Female

38

Bilateral

Lymphocyte dominant

2

Inter-follicular immunoblasts

9

Male

64

Bilateral

Lymphocyte dominant

>200

Inter-follicular small lymphocytes, immunoblasts, karyotypic irregular medium-sized lymphocytes and immunoblasts, mesenchymal spindle cells, 1-2 positive centroblasts in 2 germinal centers

10

Female

65

Left

Lymphocyte dominant

3

Inter-follicular small lymphocytes and immunoblasts

11

Female

60

Right

Lymphocyte dominant

2

Inter-follicular small lymphocytes and immunoblasts

12

Female

67

Right

Lymphocyte dominant

20

Inter-follicular small lymphocytes and immunoblasts

13

Male

35

Bilateral

Lymphocyte dominant

15

Inter-follicular small lymphocytes and immunoblasts

14

Female

68

Left

Mixed

12

Inter-follicular small lymphocytes and immunoblasts

15

Female

55

Left

Fibrous

5

Small lymphocytes

16

Male

69

Right

Mixed

11

Immunoblasts

17

Female

76

Left

Mixed

>200

Small lymphocytes, medium-sized lymphocytes, immunoblasts, and inside the nuclei of mesenchymal spindle cells

18

Female

84

Right

Mixed

40

Medium-small lymphocytes and immunoblasts

19

Male

56

Right

Mixed

6

Small lymphocytes

EBER: Epstein-Barr virus-encoded small RNA; IOIP: Idiopathic orbital inflammatory pseudotumor.

 

DISCUSSION

Using in situ hybridization, we found that IOIP tissues exhibited a total EBER-positive rate of 47.5% (19/40), resulting from latent, high-frequency infection by EBV. The cell types of the EBER-positive population mainly included small-medium-sized lymphocytes and activated immunoblasts, although several specimens also exhibited ectopic folliculargerminal centers with EBER-positive centroblasts as well as spindle cells, which proliferated in interstitial lesions and differentiated into fibroblasts/myofibroblasts. The EBER-positive cells were mainly distributed between ectopic folliculargerminal centers and lymphocytes around follicles or disseminated in infiltrated lymphocytes. Because EBER-induced activation of the innate immune system may cause immunopathological diseases associated with EBV infection[13,16-17], our data further revealed that EBERs are closely related to IOIP pathogenesis.

In the lesions, ectopic lymphoid tissues emerged in the germinal centers of B-lymphatic follicles, and the follicles exhibited irregular enlargement. Among the 21 cases in which lymphocytes were the main EBER-positive population, 18 showed development of ectopic follicular germinal centers. In addition, in the 11 specimens with a mixed subtype, three manifested similar morphological changes. These findings indicated that autoreactive B cells exhibited specific clonal expansion in response to antigens in target organs. These lymphatic tissues may therefore become acquired lymphoid tissue under conditions of EBV infection and abnormal autoimmunity and continuously proliferate upon stimulation by antigens. The morphological changes in the IOIP lesions are consistent with the autoimmunity theory by Pender[18] regarding autoreactive B cells resulting from EBV infection. Specifically, the T cells resulting from local EBV infection repeatedly attack target organs, thereby generating ectopic lymphatic follicles with germinal centers in target organs. As a consequence, a large quantity of autoreactive B cells are produced, which may be the underlying cause of autoimmune diseases after EBV infection. Hence, Dreyfus[19] proposed a potentially effective anti-viral approach by employing virus-targeting drugs such as rituximab, which depletes memory B cells, or acyclovir, which is an anti-retroviral integrase inhibitor.

A previous study demonstrated that nine IOIP plasma specimens with different histological traits exhibited high levels of EBV DNA, although the data did not elucidate the types and distribution of EBV-infected EBER-positive cells[11]. Yan et al[20] used in situ hybridization to examine 37 IOIP specimens of the lymphatic infiltration subtype and found no hybridization signal using EBER mRNA. The author suggested that EBV possibly only played a role in the initiation of IOIP; once the tumor forms, the lymphocytes gradually lose genomic fragments or the entire genome of EBV, resulting the absence of EBERs in the lesion. Moreover, prolonged preservation of paraffin specimens may also cause loss of the EBER signal. Here, we used a standardized method for the preservation of paraffin specimens, and from morphological and molecular perspectives, we revealed that two major cell components of IOIP lesions, namely lymphocytes and spindle cells, both harbored EBERs, which are the transcripts of EBV (latent infection). This finding was complementary to previous IOIP pathological studies, which have not histologically shown the types and distributions of EBV-infected cells.

Due to limitations of the research conditions, we did not use double-labeling for in situ hybridization or immunochemistry to classify EBER-positive lymphocytes in IOIP lesions, although such a method might not necessarily facilitate complete differentiation between different types of EBER-positive cells. Niedobitek et al[17] reported that double-labeling of in situ hybridization and immunochemistry were used to detect non-neoplastic lymphoid tissues and revealed that most EBER-positive cells in the lesions could not be identified via B-cell- or T-cell-specific antibodies. Another limitation was that the number of male and females subjects in the TAO group was different because male subjects often had more severe ocular symptoms than females and required orbital decompression.

In summary, this study used histological and morphological approaches to demonstrate that high-level EBER expression was present in the IOIP lesions of humans. Furthermore, our data revealed the types, distributions, and locations of EBER-positive cells. These findings are conducive for a better understanding of the underlying mechanisms of EBV infection in IOIP pathogenesis. Nonetheless, it remains to be determined whether the presence of EBERs indicates that IOIP patients are in the early stage of EBV reactivation.

ACKNOWLEDGEMENTS

Foundations: Supported by the National Natural Science Foundation of China (No.81260149; No.81360152; No.81560162); Guangxi Natural Science Foundation (No.2016GXNSFAA380301); Youth Science Foundation of Guangxi Medical University (No.GXMUYSF2014040).

Conflicts of Interest: Ren MW, None; Du Y, None; Ren S, None; Tang CY, None; He JF, None.

REFERENCES

1 Chaudhry IA, Shamsi FA, Arat YO, Riley FC. Orbital pseudotumor: distinct diagnostic features and management. Middle East Afr J Ophthalmol 2008;15(1):17-27. [CrossRef] [PMC free article] [PubMed]

2 Shen T, Chen J, Lin J, Liu R, Yan J. Concomitant idiopathic orbital inflammatory pseudotumor and thyroid-associated ophthalmopathy. J Craniofac Surg 2015;26(6):e479-e481. [CrossRef] [PubMed]

3 Xu X, Du Y, Ding Y, Ye H, Yang H. Idiopathic orbital inflammation associated with panuveitis in an adult and a review of the literature. Eye Sci 2013;28(1):40-43. [PubMed]

4 Shields JA, Shields CL. Orbital pseudotumor versus idiopathic nongranulomatous orbital inflammation. Ophthal Plast Reconstr Surg 2013;29(5):349. [CrossRef] [PubMed]

5 Li J, Ge X, Ma JM. Relationship between dacryoadenitis subtype of idiopathic orbital inflammatory pseudotumor and paranasal sinusitis. Int J Ophthalmol 2016;9(3):444-447. [PMC free article] [PubMed]

6 Bergmann KR, Schloff S, Schiff J. Contralateral recurrence of idiopathic orbital inflammatory syndrome in a pediatric patient. Minn Med 2014;97(10):46-47. [PubMed]

7 Yuen SJ, Rubin PA. Idiopathic orbital inflammation: ocular mechanisms and clinicopathology. Ophthalmol Clin North Am 2002;15(1):121-126. [CrossRef]

8 Patnana M, Sevrukov AB, Elsayes KM, Viswanathan C, Lubner M, Menias CO. Inflammatory pseudotumor: the great mimicker. AJR Am J Roentgenol 2012;198(3):W217-W227. [CrossRef] [PubMed]

9 Pender MP. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 2003;24(11):584-588. [CrossRef]

10 Bijlsma WR, Kalmann R, Dekkers J, Paridaens D, Mourits MP, Kloos R, de Groot-Mijnes JD. Identification of infectious entities in idiopathic orbital inflammation biopsies. Br J Ophthalmol 2013;97(5):664-665. [CrossRef] [PubMed]

11 Jin R, Zhao P, Ma X, Ma J, Wu Y, Yang X, Zhang J, Zhong R, Zeng Y. Quantification of Epstein-Barr virus DNA in patients with idiopathic orbital inflammatory pseudotumor. PLoS One 2013;8(1):e50812. [CrossRef] [PMC free article] [PubMed]

12 Gulley ML. Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn 2001;3(1):1-10. [CrossRef]

13 Ahmed W, Philip PS, Tariq S, Khan G. Epstein-Barr virus-encoded small RNAs (EBERs) are present in fractions related to exosomes released by EBV-transformed cells. PLoS One 2014;9(6):e99163. [CrossRef] [PMC free article] [PubMed]

14 Henderson JW. Orbital tumors. 3rd ed: Raven Press; 1994:391-411.

15 Bartley GB, Gorman CA. Diagnostic criteria for Graves' ophthalmopathy. Am J Ophthalmol 1995;119(6):792-795. [CrossRef]

16 Olson JK, Croxford JL, Miller SD. Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunol 2001;14(3):227-250. [CrossRef] [PubMed]

17 Niedobitek G, Herbst H, Young LS, Brooks L, Masucci MG, Crocker J, Rickinson AB, Stein H. Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 1992;79(10):2520-2526. [PubMed]

18 Pender MP. CD8+ T-Cell Deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis. Autoimmune Dis 2012;2012:189096. [CrossRef]

19 Dreyfus DH. Autoimmune disease: A role for new anti-viral therapies? Autoimmun Rev 2011;11(2):88-97. [CrossRef] [PubMed]

20 Yan J, Wu Z, Li Y. Detection of Epstein-Barr virus in orbital lymphocytic inflammatory pseudotumor by in situ hybridization. Yan Ke Yan Jiu 2003;21(1):50-52.